Anyone Out There Not See This One Coming???
Check this out. What you will see are recent Harris Poll results indicating that the pharmaceutical industry’s image seems to have its “halo slipping.” More quantitatively, we see that positive ratings have slid from 62% positive several months ago to 56% now. And what might that mean? Maybe lots of things, or maybe nothing!
In the “nothing” category, it should be noted that while across the year we see a gradual trend downward, the majority rating is still one of positivity. The bottom is not falling out.
Relatedly, the statisticians among our readers may interpret this as nothing more or less than a “regression toward the mean.” Translated, that means that the perception of pharmaceutical companies jumped up significantly, as we have previously discussed, when the rapid development of effective COVID-19 vaccines made us heroes. Maybe the blush is just coming off that rose a little bit.
On the other hand, pharmaceutical companies are once again being excoriated in the news. The introduction of an Alzheimer’s drug that may or may not work, and costs over $50,000 a year per patient, doesn’t help. And then the indications for using that drug getting “walked back” by the manufacturer makes matters worse. AND. The fact that the FDA is now calling for an investigation of their own doctors involved in the approval process for this drug is likely to crank our rating down yet another few notches in the eyes of the public.
Bottom Line. We said several months ago that the pharmaceutical industry had an opportunity to build on the fleeting vaccine positivity and establish a pathway to a more permanent positive public image.
Nonetheless, here we are!